Bristol-Myers Squibb Co
Stocks making the biggest premarket moves: Cleveland-Cliffs, Nucor, Moderna, Tesla and more
Check out the companies making the biggest moves in premarket trading: Steel stocks — Shares of steel companies soared after President Donald Trump doubled tariffs on the metal to 50% from 25%. Cleveland-Cliffs rallied 26%, while Nucor added nearly 11% and Steel Dynamics rose 10%. BioNTech — The Germany-based biotech stock jumped 11.3% after Bristol […]
Read More
Healthy Returns: Trump provides a glimpse of the third round of Medicare drug price negotiations
In a photo illustration, prescription drugs are seen next to a pill bottle on July 23, 2024 in New York City. Spencer Platt | Getty Images News | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to […]
Read More
Trump’s plan to slash drug prices may struggle to get off the ground – here’s what to know
President Donald Trump, joined by National Institutes of Health (NIH) Director Jay Bhattacharya, speaks during a press conference in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC. Andrew Harnik | Getty Images News | Getty Images President Donald Trump on Monday moved forward with a plan to lower U.S. […]
Read More
Stocks making the biggest moves midday: Amazon, Alibaba, Merck, Five Below, Nike and more
Check out the companies making headlines in midday trading: Drugmakers — Pharmaceutical stocks bounced back from earlier losses after an executive order aimed at bringing down drug prices was deemed not as bad as feared for the industry. Merck jumped 5%, while Pfizer , Bristol-Myers Squibb and Eli Lilly all rose more than 2%. However, […]
Read More
These 6 portfolio names pledged big U.S. investments since Trump took office again
Many of the biggest U.S. companies have pledged to invest trillions of dollars in the United States since President Donald Trump started his second term — including six names in our portfolio. These moves are aimed at aligning companies with the president’s vision for a new global trade order designed to bring manufacturing jobs back […]
Read More
Stocks making the biggest moves midday: AppLovin, Carvana, MercadoLibre, Crocs and more
Check out the companies making headlines in midday trading. AppLovin — The mobile ad tech company jumped 12% after first-quarter results that beat analyst expectations. AppLovin also announced it would sell its mobile gaming business in a $400 million deal. Carvana — Shares jumped more than 11% after the online used car marketplace posted better-than-expected […]
Read More
Stocks making the biggest moves premarket: Shopify, AppLovin, Peloton, Tapestry and more
Check out the companies making headlines in premarket trading. Shopify — Shares of the commerce technology platform dove 8.7% even after first-quarter revenue came in at $2.36 billion, beating the FactSet consensus estimate of $2.33 billion. Shopify had risen 20% over the past month, and its full year guidance set operating expenses at 39%-40% of […]
Read More
These are 3 big things we’re watching in the stock market this week
The stock market bounce last week showed once again just how dependent Wall Street has become on the whims of the White House. Case in point: The S & P 500 sank more than 2% this past Monday as President Donald Trump was attacking Federal Reserve Chairman Jerome Powell and providing scant details on tariff […]
Read More
These four stocks just entered overbought territory and could be due for a drop if volatility persists
Some stocks that investors have bought up this week could be positioned for a pullback if the market remains volatile. Stocks have seen big swings in recent weeks in reaction to the latest news about President Donald Trump’s tariffs, with investors awaiting potential deals between the U.S. and its trading partners. The president said agreements […]
Read More
Why we’re lowering our Bristol Myers price target despite an earnings beat, guidance raise
Bristol Myers Squibb ‘s earnings beat and rosy outlook Thursday did not resolve lingering issues for the stock. But it was enough, for now. Revenue in the first quarter, which ended March 31, dipped 6% to $11.2 billion but topped estimates of $10.7 billion, according to LSEG. Adjusted earnings per share of $1.80 beat expectations […]
Read More